June 7, 2016 | 7:54 AM by Fahad Khalid | fkhalid@jaguaranalytics.com

Unlock: Biogen (BIIB) Taking the Loss

(There is no shame is recognizing a loss. Things happen. It hurts but it must be acknowledged and dealt with in the same manner as winners. That’s the only way one stays genuine and keeps moving forward. The trade idea below was issued to clients on May 24. The July 300 calls had doubled in value from $5.00 to $10.00 within a few days after alert but trade was not closed. With Biogen missing primary and secondary endpoints in Multiple Sclerosis this morning, trade will be closed at a loss).

Biogen
Ticker: BIIB
Sector: Biotech / Pharma
Current Price: $270.90
Target: First $285 then $300+
Stop Loss: $256.00
Time Duration: 52 days

Trade Idea – Buy BIIB July 300 Calls for $5.00 or less.

Slightly speculative play but ahead of very important Anti-LINGO Phase 2 data expected anytime before end of June, I like buying July 300 calls for $5.00 or less. Logic explained in YouTube video, click HERE.

BIIB Chart

#BIIB
Sign up for a four-week trial!

Password must meet the following requirements: